American Journal of Physiology-Lung Cellular and Molecular Physiology · 1997 · 41 citations · 28 references
Life SciencesCell BiologyPharmacologyCell SignalingMolecular PharmacologySignal TransductionCalcium SignalingCholinergic PharmacologyIntracellular Calcium SignalingCa2+ SignalingCalcium Ion SignalingCalcium Signaling In Muscle CellsCalcium-mediated SignalingDiacylglycerol SignalingMuscarinic ReceptorsProtein Kinase InhibitorsReceptor-mediated Calcium Signaling
Muscarinic receptor stimulation increases Ca2+ sensitivity, i.e., the amount of force produced at a constant submaximal cytosolic Ca2+ concentration ([Ca2+]i), in permeabilized smooth muscle preparations. It is controversial whether this increase in Ca2+ sensitivity is in part mediated by protein kinase C (PKC). With the use of a beta-escin permeabilized canine tracheal smooth muscle (CTSM) preparation, the effect of four putative PKC inhibitors [calphostin C, chelerythrine chloride, a pseudosubstrate inhibitor for PKC [PKC peptide-(19-31)], and staurosporine] on Ca2+ sensitization induced by acetylcholine (ACh) plus GTP was determined. Preincubation with each of the inhibitors did not affect subsequent Ca2+ sensitization induced by muscarinic receptor stimulation in the presence of a constant submaximal [Ca2+]i, neither did any of these compounds reverse the increase in Ca2+ sensitivity induced by ACh plus GTP. Administration of a 1,2-diacylglycerol analog, 1-oleoyl-2-acetyl-sn-glycerol, did not induce Ca2+ sensitization at a constant submaximal [Ca2+]i. Thus we found no evidence that PKC mediates increases in Ca2+ sensitivity produced by muscarinic receptor stimulation in permeabilized CTSM.
28